A 28-year-old woman from Delhi presents with acute onset fever, headache, and neck stiffness. Lumbar puncture is performed, and cerebrospinal fluid (CSF) shows pleocytosis with predominantly neutrophils, elevated protein, and low glucose. A Gram stain of the CSF reveals Gram-negative diplococci with a kidney bean or coffee bean shape. Blood cultures and CSF cultures are sent. Which of the following structural components of this organism is the primary virulence factor that enables evasion of the complement-mediated bactericidal pathway?

Explanation

## Meningococcal Virulence and the Polysaccharide Capsule ### Clinical Diagnosis The presentation—fever, meningitis, Gram-negative kidney bean–shaped diplococci—is pathognomonic for **meningococcal meningitis** caused by *Neisseria meningitidis*. The CSF findings (pleocytosis, elevated protein, low glucose) confirm bacterial meningitis. ### The Polysaccharide Capsule as Primary Virulence Factor **Key Point:** *N. meningitidis* possesses a **polysaccharide capsule** that is the single most important virulence determinant and the primary mechanism of complement evasion. ### How the Capsule Evades Complement 1. **Inhibits C3b deposition**: The capsule's hydrophilic, negatively charged polysaccharide (serogroups A, B, C, W, Y) prevents direct binding of complement components to the bacterial cell surface. 2. **Reduces opsonization**: By masking underlying LPS and outer membrane proteins, the capsule prevents recognition by complement receptors on phagocytes. 3. **Molecular mimicry** (especially serogroup B): The capsule contains sialic acid (N-acetyl neuraminic acid) that resembles host neural tissue, reducing immune recognition. 4. **Prevents complement-mediated lysis**: Without efficient C3b and C5b-C9 deposition, the membrane attack complex (MAC) cannot form, allowing the organism to survive in blood and CSF. ### Structural Comparison of Virulence Factors | Structure | Function | Role in Virulence | |-----------|----------|-------------------| | **Polysaccharide capsule** | Inhibits complement, masks immunogenic epitopes | PRIMARY—enables survival in blood and CSF | | **Pili (fimbriae)** | Adhesion to nasopharyngeal epithelium | SECONDARY—facilitates initial colonization and invasion | | **LPS (endotoxin)** | Inflammatory mediator, triggers cytokine release | Contributes to septic shock; masked by capsule | | **Outer membrane proteins (Opa, Opc)** | Invasion and intracellular survival | Blocked from immune recognition by capsule | **High-Yield:** Unencapsulated mutants of *N. meningitidis* are **rapidly cleared** by complement and are non-virulent. The capsule is essential for invasive disease. ### Clinical Pearl **Asplenic and complement-deficient patients** are at dramatically increased risk for meningococcal sepsis because they cannot generate effective complement-mediated killing. Vaccination against meningococcal polysaccharide capsides (conjugate vaccines) is critical in these populations. ### Mnemonic **CAPSULE = Complement Avoidance Polysaccharide Shields Underlying Lipid Epitopes** [cite:Robbins 10e Ch 8; Harrison 21e Ch 139]